Search Results 71-80 of 16260 for Cystinosis%2Bagents

  1. A Study to Investigate the Effectiveness of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis - Mayo Clinic

    Inclusion Criteria: Male and female subjects aged 18 to 75 years, inclusive. IPAA for UC completed at least 1 year prior to screening.

  2. Drugs and Supplements that Start with H - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “H” to learn about drug side effects, proper use and ...

  3. Drugs and Supplements that Start with S - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “S” to learn about drug side effects, proper use and ...

  4. Assess the Long-term Safety and Effecticeness of Osilodrostat in Patients with Endogenous Cushing’s Syndrome - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. https://www.mayoclinic.org/arabic_patient_consumer_web.xml

  6. Rare Kidney Stone Consortium Patient Registry - Mayo Clinic

    The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent ...

  7. Drugs and Supplements that Start with H - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “H” to learn about drug side effects, proper use and ...

  8. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the signaling molecules needed for cell growth. Monoclonal antibodies, such as ...

  9. Drugs and Supplements that Start with P - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “P” to learn about drug side effects, proper use and ...

  10. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    PI3K-delta inhibitor TGR-1202 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as ...